Pfizer (PFE) Cash from Operations (2009 - 2026)
Pfizer (PFE) reported Cash from Operations of 2615000000.0 for Q1 2026, up 11.99% year-over-year from 2335000000.0 in Q1 2025, and down 51.1% on a QoQ basis from 5348000000.0 in Q4 2025.
Pfizer (PFE) has 18 years of Cash from Operations data on file, last reported at 2615000000.0 in Q1 2026.
- Quarterly Cash from Operations rose 11.99% year-over-year to 2615000000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11984000000.0 (up 56.31% YoY) and the FY2025 annual result came in at 11704000000.0, down 8.16% from the prior year.
- Cash from Operations retreated to 2615000000.0 in Q1 2026 per PFE's latest filing, from 5348000000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 20685000000.0 in Q4 2022 and bottomed at 1781000000.0 in Q2 2024.
- The 5-year median for Cash from Operations is 3456000000.0 (2023), against an average of 4249800000.0.
- The widest annual swing landed in 2023, when Cash from Operations sank 114.79%; it then soared 114.22% in 2025.
- Tracing PFE's Cash from Operations over 5 years: stood at 20685000000.0 in 2022, then slumped by 74.67% to 5240000000.0 in 2023, then grew by 14.94% to 6023000000.0 in 2024, then fell by 11.21% to 5348000000.0 in 2025, then sank by 51.1% to 2615000000.0 in 2026.
- Per Business Quant, the three latest PFE Cash from Operations figures stand at 2615000000.0 (Q1 2026), 5348000000.0 (Q4 2025), and 4603000000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 5.33 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 2.51 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 3.83 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 3.92 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.19 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 2.54 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 2.62 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 1.10 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 2.62 Bn |
| Mar 29, 2026 | 2.62 Bn |
| Dec 31, 2025 | 5.35 Bn |
| Dec 31, 2025 | 5.35 Bn |
| Sep 28, 2025 | 4.60 Bn |
| Sep 28, 2025 | 4.60 Bn |
| Jun 29, 2025 | -582.00 Mn |
| Jun 29, 2025 | -582.00 Mn |
| Mar 30, 2025 | 2.34 Bn |
| Mar 30, 2025 | 2.34 Bn |
| Sep 29, 2024 | 6.02 Bn |
| Sep 29, 2024 | 6.02 Bn |
| Jun 30, 2024 | -1.78 Bn |
| Jun 30, 2024 | -1.78 Bn |
| Mar 31, 2024 | 1.09 Bn |
| Mar 31, 2024 | 1.09 Bn |
| Dec 31, 2023 | 5.24 Bn |
| Dec 31, 2023 | 5.24 Bn |
| Oct 1, 2023 | 3.46 Bn |
| Oct 1, 2023 | 3.46 Bn |
| Jul 2, 2023 | -1.21 Bn |
| Jul 2, 2023 | -1.21 Bn |
| Apr 2, 2023 | 1.21 Bn |
| Apr 2, 2023 | 1.21 Bn |
| Oct 2, 2022 | 20.69 Bn |
| Oct 2, 2022 | 20.69 Bn |
| Jul 3, 2022 | 8.17 Bn |
| Jul 3, 2022 | 8.17 Bn |
| Apr 3, 2022 | 6.54 Bn |
| Apr 3, 2022 | 6.54 Bn |
| Oct 3, 2021 | 26.99 Bn |
| Oct 3, 2021 | 26.99 Bn |
| Jul 4, 2021 | 11.30 Bn |
| Jul 4, 2021 | 11.30 Bn |
| Apr 4, 2021 | 4.54 Bn |
| Apr 4, 2021 | 4.54 Bn |
| Sep 27, 2020 | 6.36 Bn |
| Sep 27, 2020 | 6.36 Bn |
| Jun 28, 2020 | 4.53 Bn |
| Jun 28, 2020 | 4.53 Bn |
| Mar 29, 2020 | 2.16 Bn |
| Mar 29, 2020 | 2.16 Bn |
| Dec 31, 2019 | 3.77 Bn |
| Dec 31, 2019 | 3.77 Bn |
| Sep 29, 2019 | 4.51 Bn |
| Sep 29, 2019 | 4.51 Bn |
| Jun 30, 2019 | 2.61 Bn |
| Jun 30, 2019 | 2.61 Bn |
| Mar 31, 2019 | 1.70 Bn |
| Mar 31, 2019 | 1.70 Bn |
| Dec 31, 2018 | -2.21 Bn |
| Dec 31, 2018 | -2.21 Bn |
| Sep 30, 2018 | 5.26 Bn |
| Sep 30, 2018 | 5.26 Bn |
| Jul 1, 2018 | 3.85 Bn |
| Jul 1, 2018 | 3.85 Bn |
| Apr 1, 2018 | 1.98 Bn |
| Apr 1, 2018 | 1.98 Bn |
| Dec 31, 2017 | 7.09 Bn |
| Dec 31, 2017 | 7.09 Bn |
| Oct 1, 2017 | 4.89 Bn |
| Oct 1, 2017 | 4.89 Bn |
| Jul 2, 2017 | 3.24 Bn |
| Jul 2, 2017 | 3.24 Bn |
| Apr 2, 2017 | 1.58 Bn |
| Apr 2, 2017 | 1.58 Bn |
| Dec 31, 2016 | 6.04 Bn |
| Dec 31, 2016 | 6.04 Bn |
| Oct 2, 2016 | 4.74 Bn |
| Oct 2, 2016 | 4.74 Bn |
| Jul 3, 2016 | 3.61 Bn |
| Jul 3, 2016 | 3.61 Bn |
| Apr 3, 2016 | 1.81 Bn |
| Apr 3, 2016 | 1.81 Bn |
| Dec 31, 2015 | 4.90 Bn |
| Dec 31, 2015 | 4.90 Bn |
| Sep 27, 2015 | 5.02 Bn |
| Sep 27, 2015 | 5.02 Bn |
| Jun 28, 2015 | 4.09 Bn |
| Jun 28, 2015 | 4.09 Bn |
| Mar 29, 2015 | 680.00 Mn |
| Mar 29, 2015 | 680.00 Mn |
| Dec 31, 2014 | 5.60 Bn |
| Dec 31, 2014 | 5.60 Bn |
| Sep 28, 2014 | 4.46 Bn |
| Sep 28, 2014 | 4.46 Bn |
| Jun 29, 2014 | 4.09 Bn |
| Jun 29, 2014 | 4.09 Bn |
| Mar 30, 2014 | 2.94 Bn |
| Mar 30, 2014 | 2.94 Bn |
| Dec 31, 2013 | 5.72 Bn |
| Dec 31, 2013 | 5.72 Bn |
| Sep 29, 2013 | 5.90 Bn |
| Sep 29, 2013 | 5.90 Bn |
| Jun 30, 2013 | 3.76 Bn |
| Jun 30, 2013 | 3.76 Bn |
| Mar 31, 2013 | 2.30 Bn |
| Mar 31, 2013 | 2.30 Bn |
| Dec 31, 2012 | 4.95 Bn |
| Dec 31, 2012 | 4.95 Bn |
| Sep 30, 2012 | 5.00 Bn |
| Sep 30, 2012 | 5.00 Bn |
| Jul 1, 2012 | 4.02 Bn |
| Jul 1, 2012 | 4.02 Bn |
| Apr 1, 2012 | 2.77 Bn |
| Apr 1, 2012 | 2.77 Bn |
| Dec 31, 2011 | 5.26 Bn |
| Dec 31, 2011 | 5.26 Bn |
| Oct 2, 2011 | 4.44 Bn |
| Oct 2, 2011 | 4.44 Bn |
| Jul 3, 2011 | 5.90 Bn |
| Jul 3, 2011 | 5.90 Bn |
| Apr 3, 2011 | 4.64 Bn |
| Apr 3, 2011 | 4.64 Bn |
| Dec 31, 2010 | 6.26 Bn |
| Dec 31, 2010 | 6.26 Bn |
| Oct 3, 2010 | 6.68 Bn |
| Oct 3, 2010 | 6.68 Bn |
| Jul 4, 2010 | 4.87 Bn |
| Jul 4, 2010 | 4.87 Bn |
| Apr 4, 2010 | -6.36 Bn |
| Apr 4, 2010 | -6.36 Bn |
| Dec 31, 2009 | 4.83 Bn |
| Dec 31, 2009 | 4.83 Bn |
| Sep 27, 2009 | 4.10 Bn |
| Sep 27, 2009 | 4.10 Bn |
| Jun 28, 2009 | 4.51 Bn |
| Jun 28, 2009 | 4.51 Bn |
| Mar 29, 2009 | 3.15 Bn |
| Mar 29, 2009 | 3.15 Bn |